Skip to content

Clinical trials

Active, not recruiting Central Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Active, not recruiting Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20202
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4D Molecular Therapeutics1
Bial R&D Investments, S.A.1
Centre hospitalier de l'Université de Montréal (CHUM)1
EIP Pharma Inc1
Eli Lilly and Company1
Emalex Biosciences Inc.1
Forge Biologics, Inc1
Sage Bionetworks1
Thomas Jefferson University1
iECURE, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases10
Brain Diseases7
Nervous System Diseases7
Neurodegenerative Diseases6
Movement Disorders4
Brain Diseases, Metabolic3
Genetic Diseases, Inborn3
Mental Disorders3
Metabolic Diseases3
Parkinson Disease3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.